ACADSB: Short/Branched Chain Acyl-CoA Dehydrogenase

Key enzyme in mitochondrial fatty acid and branched-chain amino acid metabolism

Gene Information Card

Symbol ACADSB
Full Name Acyl-CoA Dehydrogenase, Short/Branched Chain
Gene Type Protein coding
Chromosomal Location 10q26.13
NCBI Gene ID 36 ncbi.nlm.nih.gov/gene/36
Ensembl ID ENSG00000138185
UniProt ID Q9H845
OMIM ID 600301
HGNC ID 91
Aliases SBCAD, 2-MEBCAD, ACAD7

Description

The ACADSB gene encodes the short/branched chain acyl-CoA dehydrogenase (SBCAD), a mitochondrial enzyme involved in the catabolism of branched-chain amino acids (isoleucine, valine) and short-chain fatty acids. It catalyzes the alpha,beta-dehydrogenation of acyl-CoA derivatives, specifically 2-methylbutyryl-CoA (from isoleucine) and isobutyryl-CoA (from valine). Deficiency leads to 2-methylbutyryl glycinuria (OMIM #610006), a disorder of isoleucine metabolism with variable clinical severity.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
2-Methylbutyryl Glycinuria (ACADSB deficiency) Loss of SBCAD enzyme activity impairs isoleucine catabolism, leading to accumulation of 2-methylbutyryl-CoA and its glycine conjugate. ClinVar, OMIM #610006
Short-chain acyl-CoA dehydrogenase deficiency (SCAD deficiency) ACADSB mutations can mimic SCAD deficiency due to overlapping substrate specificity. NCBI Gene, ClinVar
Encephalopathy, acute neonatal Severe ACADSB deficiency may present with metabolic crisis, hypotonia, and developmental delay. OMIM, ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.3 Medium
Kidney 8.7 Medium
Heart 6.5 Low
Skeletal Muscle 4.2 Low
Brain 3.1 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 10.5 Hepatocellular carcinoma cell line
HEK293 7.8 Embryonic kidney cells
K562 2.1 Leukemia cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1165A>G (p.Thr389Ala) Missense 0.01% (gnomAD) Reduced enzyme activity; associated with 2-methylbutyryl glycinuria
c.124C>T (p.Arg42Cys) Missense <0.01% Loss of function; pathogenic in ClinVar
c.1A>G (p.Met1Val) Start loss <0.01% Complete loss of translation; pathogenic
Mutation functional classification

Loss of Function (LOF)

Most ACADSB disease-associated mutations are loss-of-function, reducing or abolishing enzyme activity, leading to substrate accumulation.

Gain of Function (GOF)

No gain-of-function mutations reported.

Dominant Negative (DN)

No dominant-negative effects documented; inheritance is autosomal recessive.

Gene Ontology (GO)

• GO:0003995 - acyl-CoA dehydrogenase activity • GO:0050660 - flavin adenine dinucleotide binding
• GO:0005739 - mitochondrion • GO:0006552 - isoleucine catabolic process
• GO:0006573 - valine catabolic process • GO:0033539 - fatty acid beta-oxidation

Pathways

Valine
leucine and isoleucine degradation (KEGG: hsa00280)
Fatty acid degradation (KEGG: hsa00071)
Metabolic pathways (KEGG: hsa01100)

Protein Summary

The SBCAD protein (UniProt Q9H845) is a homotetrameric mitochondrial flavoenzyme of 418 amino acids. It contains a conserved acyl-CoA dehydrogenase domain and FAD-binding site. The enzyme catalyzes the third step in isoleucine and valine catabolism, converting 2-methylbutyryl-CoA to tiglyl-CoA and isobutyryl-CoA to methacrylyl-CoA, respectively. Defects cause metabolic disorder with urinary excretion of 2-methylbutyryl glycine.

Related Products

Product name Cat.No. Species Gene ID
ACADSB Knockout HEK293 Cell Line EDJ-KQ3993 Human 36 Details Get a Quote
ACADSB Knockout A-549 Cell Line EDJ-KQ24966 Human 36 Details Get a Quote
ACADSB Knockout HCT 116 Cell Line EDJ-KQ26312 Human 36 Details Get a Quote
ACADSB Knockout HeLa Cell Line EDJ-KQ26313 Human 36 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: